Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Beverly Hills, California


The primary objective of this study is to evaluate the efficacy and safety of fibrin sealant with 4 IU/mL thrombin, vapor heated, solvent detergent treated (FS VH S/D 4) when used to reduce early postoperative bruising in participants undergoing a rhytidectomy (face-lift).


Inclusion Criteria: - Subjects planned for facial rhytidectomy - Subjects who read, understand and sign the written informed consent - Healthy female or male subjects as determined by the investigator using standard pre-operative assessments to include laboratory tests and ECG - Subjects 18-75 years old, inclusively - Subjects who are able and willing to comply with the protocol requirements - Female subjects of childbearing potential with a negative urine or serum pregnancy test within 72 hours of surgery Exclusion Criteria: - Pregnant or lactating women - Subjects who have undergone previous face-lift surgery - Subjects undergoing abbreviated face-lift procedures such as deep plane procedures, minimal undermining procedures, thread lifts, and minimal access cranial suspension - Subjects indicated for concurrent facial surgeries during the operation (e.g. forehead plasty, blepharoplasty, rhinoplasty, buccal fat removal, any filler injections including fat injections, lip augmentation, skin resurfacing procedures etc.) - Subjects indicated for additional procedures during the same operation (e.g., liposuction, mastoplasty etc.) - Subjects who had prior silicone injections to their face (Botox and/or Restylane are allowed) - Subjects considered by the investigator to be smokers - Subjects with ecchymosis and/or edema on the face on day 0, prior to surgery - Subjects with known (documented) bleeding or coagulation disorders - Subjects currently being treated with anti-coagulants - Subjects treated with Aspirin in the last 7 days or use of other Non-steroidal anti-inflammatory drug (NSAIDs) within the last 7 days prior to surgery - Subjects with vascular disorders, cardiovascular disease, and/or uncontrolled hypertension - Subjects with diabetes mellitus - Subjects with a history of Bell´s palsy - Subjects with connective tissue disorders - Subjects with documented history of pathologically or pharmacologically induced immune deficiency - Subjects receiving systemic corticosteroid treatment for a chronic condition within 2 to 30 days prior to the surgery - Subjects with a known sensitivity to fibrin sealants - Subjects with a known psychiatric disorder (e.g., depression, obsessive compulsive disorder, anxiety, eating disorders, etc) - Subjects who have participated in another clinical study within 30 days prior to this study



Primary Contact:

Study Director
Steve Z Abrams, MD
Baxter Healthcare Corporation

Backup Contact:


Location Contact:

Beverly Hills, California
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.